# EDGAR Filing Document

**Accession Number:** 0001854183
**File Stem:** 0001683168-23-001435
**Filing Date:** 2023-3
**Character Count:** 40484
**Document Hash:** fcc07f258b958999303256ceff32cd04
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001683168-23-001435.hdr.sgml**: 20230313

**ACCESSION NUMBER**: 0001683168-23-001435

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 37

**CONFORMED PERIOD OF REPORT**: 20230131

**FILED AS OF DATE**: 20230313

**DATE AS OF CHANGE**: 20230313

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Orion Bliss Corp.
- **CENTRAL INDEX KEY:** 0001854183
- **STANDARD INDUSTRIAL CLASSIFICATION:** SOAP, DETERGENT, CLEANING PREPARATIONS, PERFUMES, COSMETICS [2840]
- **IRS NUMBER:** 981591444
- **STATE OF INCORPORATION:** NV

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 333-257326
- **FILM NUMBER:** 23725786

**BUSINESS ADDRESS:**
- **STREET 1:** 3773 HOWARD HUGHES PKWY,
- **STREET 2:** SUITE 500S
- **CITY:** LAS VEGAS
- **STATE:** NV
- **ZIP:** 89169-6014
- **BUSINESS PHONE:** 702-751-3560

**MAIL ADDRESS:**
- **STREET 1:** 3773 HOWARD HUGHES PKWY,
- **STREET 2:** SUITE 500S
- **CITY:** LAS VEGAS
- **STATE:** NV
- **ZIP:** 89169-6014

?xml version="1.0" encoding="utf-8"?

[**Table of Contents**](#a_001)

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 10-Q** 

Mark One

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended January 31, 2023

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______ to _______

Commission File No. 333-257326

**ORION BLISS CORP.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Nevada** | **2840** | **EIN 98-1591444** |
| (State or other jurisdiction of incorporation or Organization) | (Primary Standard Industrial Classification Code Number) | (IRS Employer Identification Number) |

---

**Ashdod**

**Kalonite 9-57**

**Israel** 

**7724233**

**Tel+18498593819**

**Email: orionbliss123456@gmail.com**

(Address, including zip code, and telephone number,

including area code, of registrant's principal executive offices)

Indicate by checkmark whether the issuer: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer", "smaller reporting company", and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one)

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

Indicate by checkmark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

Applicable Only to Issuer Involved in Bankruptcy Proceedings During the Preceding Five Years. N/A

Indicate by checkmark whether the issuer has filed all documents and reports required to be filed by Section 12, 13 and 15(d) of the Securities Exchange Act of 1934 after the distribution of securities under a plan confirmed by a court. Yes ☐ No ☒

Applicable Only to Corporate Registrants

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the most practicable date:

---

| | |
|:---|:---|
| Class | Outstanding as of January 31, 2023 |
| Common Stock: $0.0001 | 3038000 |

---

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| PART 1 | [*FINANCIAL INFORMATION*](#a_002) |  |
| *Item 1* | [*Financial Statements (Unaudited)*](#a_003) | 3 |
|  | [*Condensed Balance Sheets as of January 31, 2023 (unaudited) and April 30, 2022 (audited)*](#a_004) | 3 |
|  | [*Condensed Statement of Operations for the three and nine months ended January 31, 2023 and 2022 (Unaudited)*](#a_005) | 4 |
|  | [*Condensed Statement of Stockholders' Equity (Deficit) from Inception ended January 31, 2023 (Unaudited)*](#a_006) | 5 |
|  | [*Condensed Statement of Cash Flows for the nine months ended January 31, 2023 and 2022 (Unaudited)*](#a_007) | 6 |
|  | [*Notes to the Condensed Financial Statements (Unaudited)*](#a_008) | 7 |
| *Item 2.* | [*Management's Discussion and Analysis of Financial Condition and Results of Operations*](#a_009) | 11 |
| *Item 3.* | [*Quantitative and Qualitative Disclosures About Market Risk*](#a_010) | 12 |
| *Item 4.* | [*Controls and Procedures*](#a_011) | 12 |
| *PART II.* | [*OTHER INFORMATION*](#a_013) | 13 |
| *Item 1* | [*Legal Proceedings*](#a_014) | 13 |
| *Item 2.* | [*Unregistered Sales of Equity Securities and Use of Proceeds*](#a_015) | 13 |
| *Item 3* | [*Defaults Upon Senior Securities*](#a_016) | 13 |
| *Item 4* | [*Mine safety disclosures*](#a_017) | 13 |
| *Item 5* | [*Other Information*](#a_018) | 13 |
| *Item 6* | [*Exhibits*](#a_019) | 13 |
|  | [*Signatures*](#a_012) | 14 |

---

**PART I. FINANCIAL INFORMATION**

*ITEM 1. FINANCIAL INFORMATION*

**ORION BLISS CORP.**

**BALANCE SHEETS**

---

| | | |
|:---|:---|:---|
|  | **January 31, 2023** | **April 30, 2022** |
| **ASSETS** | (Unaudited) | (Audited) |
| Current Assets |  |  |
| &nbsp;&nbsp;&nbsp;Escrow Account | $13735 | $– |
| &nbsp;&nbsp;&nbsp;Website Development, net | 134 | 134 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Current Assets | $13869 | $134 |
| **LIABILITIES AND STOCKHOLDERS' DEFICIT** |  |  |
| Current Liabilities |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable- Related party | $22000 | $13000 |
| &nbsp;&nbsp;&nbsp;Director loan | 19752 | 15549 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Current Liabilities | 41751 | 28549 |
| Stockholders' Deficit |  |  |
| &nbsp;&nbsp;&nbsp;Common stock, par value $0.0001; 75,000,000 shares authorized, 3,038,000 and 2,000,000 shares issued and outstanding respectively; | 304 | 200 |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital | 20656 |  |
| &nbsp;&nbsp;&nbsp;Accumulated deficit | (48843) | (28615) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Stockholders' Deficit | (27883) | (28415) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Liabilities and Stockholders' Deficit | $13869 | $134 |

---

 

*The accompanying notes are an integral part of these condensed financial statements*

**ORION BLISS CORP.**

**CONDENSED STATEMENT OF OPERATIONS**

**(Unaudited)** 

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three** <br> **months ended** <br> **January 31, 2023** | **Three**<br> **months ended January 31, 2022** | **Nine**<br> **months ended January 31, 2023** | **Nine**<br> **months ended January 31, 2022** |
| **REVENUES (Consulting services)** | $– | $– | $600 | $– |
| **General and Administrative Expenses** | 6674 | 5454 | 20828 | 19050 |
| **NET INCOME (LOSS) FROM OPERATION** | (6674) | (5454) | (20228) | (19050) |
| **PROVISION FOR TAXES** | – | – | – | – |
| **NET INCOME (LOSS)** | $(6674) | $(5454) | $(20228) | $(19050) |
| **NET LOSS PER SHARE: BASIC AND DILUTED** | $(0.00) | $(0.00) | $(0.00) | $(0.00) |
| **WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED** | 2975304 | 2000000 | 2464111 | 2000000 |

---

 

*The accompanying notes are an integral part of these condensed financial statements*

**ORION BLISS CORP.**

**STATEMENTS OF STOCKHOLDER EQUITY (Unaudited)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Common Stock** | **Common Stock** | | | |
|  | **Shares** | **Amount** | **Additional <br> Paid-in**<br>**Capital** | **Deficit<br> Accumulated<br> during the<br> Development**<br>**Stage** | **Total<br> Stockholders'**<br>**Equity** |
| **Inception, March 23, 2021** | **–** | $**–** | $**–** | $**–** | $**–** |
| Shares issued for cash at $0.0001 per share on April 15, 2021 | 2000000 | 200 |  |  | 200 |
| Net loss for the year ended April 30, 2021 | – | – | – | (1925) | (1925) |
| **Balance, April 30, 2021** | **2000000** | **200** | **–** | **(1925)** | **(1725)** |
| Net loss for the year ending April 30, 2022 | – | – | – | (26690) | (26690) |
| **Balance, April 30, 2022** | **2000000** | **200** | **–** | **(28615)** | **(28415)** |
| Shares issued for cash at $0.02 per share in July, 2022 | 65500 | 7 | 1303 |  | 1310 |
| Net loss for the quarter ending July 31, 2022 | – | – | – | (8636) | (8636) |
| **Balance, July 31, 2022** | **2065500** | **207** | **1303** | **(37251)** | **(35741)** |
| Shares issued for cash at $0.02 per share in September and October, 2022 | 822500 | 82 | 16368 |  | 16450 |
| Net loss for the quarter ending October 31, 2022 | – | – | – | (5521) | (5521) |
| **Balance, October 31, 2022** | **2888000** | **289** | **17671** | **(42169)** | **(24209)** |
| Shares issued for cash at $0.02 per share in September and January, 2023 | 150000 | 15 | 2985 |  | 3000 |
| Net loss for the quarter ending January 31, 2023 | – | – | – | (6674) | (6674) |
| **Balance, January 31, 2023** | **3038000** | $**304** | $**20656** | $**(48843)** | $**(27883)** |

---

*The accompanying notes are an integral part of these condensed financial statements*

**ORION BLISS CORP.**

**CONDENSED STATEMENT OF CASH FLOWS**

**(Unaudited)** 

---

| | | |
|:---|:---|:---|
|  | **Nine months**<br> **ended** <br> **January 31, 2023** | **Nine months**<br> **ended** <br> **January 31, 2022** |
| **CASH FLOWS FROM OPERATING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;Net income (loss) for the period | $(20228) | $(19050) |
| Adjustments to reconcile net loss to net cash used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Website Development |  | (134) |
| Changes in assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;CASH FLOWS USED IN OPERATING ACTIVITIES | (20228) | (19184) |
| **CASH FLOWS FROM FINANCING ACTIVITIES** |  |  |
| Proceeds from issuing common stock at $0.02 per share | 20760 |  |
| Accounts Payable- Related Party | 9000 | 9000 |
| Related Party loans | 4203 | 10184 |
| &nbsp;&nbsp;&nbsp;CASH FLOWS PROVIDED BY FINANCING ACTIVITIES | 33963 | 19184 |
| **Net Cash Increase (Decrease) for Period** | 13735 |  |
| **Cash at the beginning of Period** | – | – |
| **Cash at end of Period** | $13735 | $– |
| **SUPPLEMENTAL CASH FLOW INFORMATION:** |  |  |
| &nbsp;&nbsp;&nbsp;Interest paid | $– | $– |
| &nbsp;&nbsp;&nbsp;Income taxes paid | $– | $– |

---

 

 

*The accompanying notes are an integral part of these condensed financial statements*

**ORION BLISS CORP.**

**Notes to the Condensed Financial Statements**

**January 31, 2023 and 2022**

**(Unaudited)**

**Note 1 – ORGANIZATION AND NATURE OF BUSINESS**

Orion Bliss Corp. (referred as the "Company", "we", "our") was Incorporated in the State of Nevada and established on March 23, 2021. We are a development-stage company formed to commence operations related to selling Milk_shake hairline products. We have website which is being developed at http://orionbliss.co.il.

Our office is located at Kalonite 9-5, Ashdod, Israel, zip code 7724233

**Note 2 – GOING CONCERN**

The accompanying financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America ("GAAP"), which contemplate continuation of the Company as a going concern. The Company has an accumulated deficit of $48,843 as of January 31, 2023 and $28,615 as of April 30, 2022. The Company currently has losses and has not completed its efforts to establish a stabilized source of revenues sufficient to cover operating costs over an extended period of time. Therefore, there is substantial doubt about the Company's ability to continue as a going concern. Management anticipates that the Company will be dependent, for the near future, on additional investment capital to fund operating expenses. The Company intends to position itself so that it will be able to raise additional funds through the capital markets. In light of management's efforts, there are no assurances that the Company will be successful in this or any of its endeavors or become financially viable and continue as a going concern.

**Note 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

***Basis of presentation***

The accompanying unaudited condensed financial statements have been prepared in accordance with the rules and regulations (Regulation S-X) of the Securities and Exchange Commission (the "SEC") and with the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The results of operations for the three and nine-months ended January 31, 2023, are not necessarily indicative of the operating results that may be expected for the year ending April 30, 2022. These unaudited condensed financial statements should be read in conjunction with the April 30, 2022, financial statements and notes thereto.

***Use of Estimates***

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

***Deferred Offering Costs***

Financial Accounting Standard Board Accounting Standards Codification number 340-10-S99-1, *Other Assets and Deferred Costs*, allows specific, incremental costs directly related to securities offerings to be deferred and charged against the gross proceed of the offering. The Company defers applicable syndication expenses based on these criteria. The Company will write off all deferred offering costs if a securities offering is aborted.

***Cash and Cash Equivalents***

 ****

The Company considers all highly liquid investments with the original maturities of three months or less to be cash equivalents.

***Fair Value of Financial Instruments***

Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 820 "Fair Value Measurement" defines fair value as the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The standards apply to recurring and nonrecurring fair value measurements of financial and non-financial assets and liabilities. The Company determines the fair values of its assets and liabilities based on a fair value hierarchy that includes three levels of inputs that may be used to measure fair value.

For The three levels are defined as follows:

---

| | |
|:---|:---|
| Level 1: | defined as observable inputs such as quoted prices in active markets; |
| Level 2: | defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and |
| Level 3: | defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. |

---

Due to its short-term nature, the carrying value of receivables, accounts payable, and advances approximated fair value at January 31, 2023.

***Income Taxes***

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized.

***Long-Lived Assets – Intangible Assets***

 ****

We account for our intangible assets in accordance with ASC Subtopic 350-30, General Intangibles Other Than Goodwill, and ASC Subtopic 360-10-05, Accounting for the Impairment or Disposal of Long-Lived Assets. ASC Subtopic 350-30 requires assets to be measured based on the fair value of the consideration given or the fair value of the assets (or net assets) acquired, whichever is more clearly evident and, thus, more reliably measurable. Further, ASC Subtopic 350-30 requires an intangible asset to be amortized over its useful life and for the useful life to be evaluated every reporting period to determine whether events or circumstances warrant a revision to the remaining period of amortization. If the estimate of useful life is changed the remaining carrying amount of the intangible asset is amortized prospectively over the revised remaining useful life. Costs of internally developing, maintaining, or restoring intangible assets are recognized as an expense when incurred.

***Basic Income (Loss) Per Share***

The Company computes income (loss) per share in accordance with FASB ASC 260 "Earnings per Share." Basic loss per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. As of January 31, 2023, there were no potentially dilutive debt or equity instruments issued or outstanding.

***Recent Accounting Pronouncements***

We have reviewed all the recently issued, but not yet effective, accounting pronouncements and we do not believe any of these pronouncements will have a material impact on the Company.

***Risks and Uncertainties***

In December 2020, a novel strain of coronavirus (COVID-19) emerged in Wuhan, Hubei Province, China. While initially the outbreak was largely concentrated in China and caused significant disruptions to its economy, it has now spread to several other countries and infections have been reported globally.

The ultimate impact of the COVID-19 pandemic on the Company's operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, reduced customer traffic and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time but is anticipated to have a material adverse impact on our business, financial condition and results of operations.

Management expects that its business will be impacted to some degree, but the significance of the impact of the COVID-19 outbreak on the Company's business and the duration for which it may have an impact cannot be determined at this time.

***Financial Statement Reclassification***

Certain account balances from prior periods have been reclassified in these financial statements to conform to current period classifications.

**Note 4 – COMMON STOCK**

The Company has 75,000,000, $0.0001 par value shares of common stock authorized.

On April 15, 2022 the Company issued 2,000,000 shares of common stock to a director for services rendered estimated to be $200 at $0.0001 per share.

In July, 2023, the Company issued 65,500 shares of common stock to 3 shareholders in consideration of $1,310.

In September and January 2023, the Company issued 822,500 shares of common stock to 29 shareholders at $0.02 per share in consideration of $16,450.

In November and December 2022 followed by January 2023, the Company issued 150,000 shares of common stock to 5 shareholders at $0.02 per share in consideration of $3,000.

There were 3,038,000 shares of common stock issued and outstanding as of January 31, 2023.

*Voting Common Stock*

All shares of common stock have voting rights and are identical. All holders of shares of voting common stock shall at every meeting of the stockholders be entitled to one vote for each share of the capital stock held by such stockholder.

*Non-voting Common Stock*

All of the other terms of the Non-Voting Common Stock shall be identical to the Voting Common Stock, except for the right of first refusal that attaches to the Non-Voting Common Stock, as explained in the Company's Bylaws.

**Note 5 – *INCOME TAXES***

On December 22, 2017, the President of the United States signed into law the Tax Cuts and Jobs Act ("Tax Reform Act"). The legislation significantly changes U.S. tax law by, among other things, lowering corporate income tax rates, implementing a territorial tax system and imposing a transition tax on deemed repatriated earnings of foreign subsidiaries. The Tax Reform Act permanently reduces the U.S. corporate income tax rate from a maximum of 35% to a flat 21% rate, effective January 1, 2018.

The reconciliation of income tax benefit (expenses) at the U.S. statutory rate at 21% for the period ended as follows:

---

| | |
|:---|:---|
| **Schedule of income tax benefit (expense)** | January 31, 2023 |
| Tax benefit (expenses) at U.S. statutory rate | $(1402) |
| Change in valuation allowance | 1402 |
| Tax benefit (expenses), net | $– |

---

The tax effects of temporary differences that give rise to significant portions of the net deferred tax assets are as follows:

---

| | |
|:---|:---|
| **Schedule of deferred tax assets** | January 31, 2023 |
| Net operating loss | $(10257) |
| Valuation allowance | 10257 |
| Deferred tax assets, net | $– |

---

The Company has accumulated approximately $48,843 of net operating losses ("NOL") carried forward to offset future taxable income up to 20 years, if any, in future years which begin to expire in year 2038. In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. Based on the assessment, management has established a full valuation allowance against all of the deferred tax asset relating to NOLs for every period because it is more likely than not that all of the deferred tax asset will not be realized.

**Note 6 – COMMITMENTS AND CONTINGENCIES**

Our sole officer and director, Alexandra Solomovskaya, has agreed to provide her own premise under office needs. She will not take any fee for these premises it is for free use.

Management expects that its business will be impacted to some degree, but the significance of the impact of the COVID-19 outbreak on the Company's business and the duration for which it may have an impact cannot be determined at this time.

**Note 7 – SUBSEQUENT EVENTS**

In accordance with ASC 855-10 the Company has analyzed its operations subsequent to January 31, 2023 to the date these financial statements were issued, and has determined that it does not have any material subsequent events to disclose in these financial statements.

<u>ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION</u>

FORWARD LOOKING STATEMENTS

Statements made in this Form 10-Q that are not historical or current facts are "forward-looking statements" made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 (the "Act") and Section 21E of the Securities Exchange Act of 1934. These statements often can be identified by the use of terms such as "may," "will," "expect," "believe," "anticipate," "estimate," "approximate" or "continue," or the negative thereof. We intend that such forward-looking statements be subject to the safe harbors for such statements. We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Any forward-looking statements represent management's best judgment as to what may occur in the future. However, forward-looking statements are subject to risks, uncertainties and important factors beyond our control that could cause actual results and events to differ materially from historical results of operations and events and those presently anticipated or projected. We disclaim any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statement or to reflect the occurrence of anticipated or unanticipated events.

Employees and Employment Agreements

At present, we have no employees other than our officer and director. We presently do not have pension, health, annuity, insurance, stock options, profit sharing or similar benefit plans; however, we may adopt such plans in the future. There are presently no personal benefits available to any officers, directors or employees.

*<u>Results of Operation</u>*

Our financial statements have been prepared assuming that we will continue as a going concern and, accordingly, do not include adjustments relating to the recoverability and realization of assets and classification of liabilities that might be necessary should we be unable to continue in operation.

We expect we will require additional capital to meet our long-term operating requirements. We expect to raise additional capital through, among other things, the sale of equity or debt securities.

*<u>Three and Nine Months Ended January 31, 2023 and 2022:</u>*

 

During three months ended January 31, 2023 the Company has not generated any revenue.

During nine months ended January 31, 2023 the Company has generated $600 in consulting services income.

Our net loss for the three and nine months ended January 31, 2023 was $6,674 and $20,228. Operating expenses consist of mainly professional fees.

Our net loss for the three and nine months ended January 31, 2022 was $5,454 and $19,050. Operating expenses consist of mainly professional fees.

*<u>Liquidity and Capital Resources</u>*

As of January 31, 2023, our total assets were $13,869 consisting of website development, net of $134 and cash 13,735 from issuance of common stock. As of January 31, 2023, our current liabilities were $41,751 consisting of accounts payable -related party advances of $22,000, and director loan of $19,752.

*<u>Cash Flows from Operating Activities</u>*

We have not generated positive cash flows from operating activities. For the nine months ended January 31, 2023, net cash flows used in operating activities were $20,228.

We have not generated positive cash flows from operating activities. For the nine months ended January 31, 2022, net cash flows used in operating activities were $19,184.

*<u>Cash Flows from Investing Activities</u>*

 

We have not generated cash flows from investing activities during the three months ended January 31, 2023 and 2022.

*<u>Cash Flows from Financing Activities</u>*

We have generated cash flows from financing activities in the amount $33,963 during the nine months ended January 31, 2023. During the nine months ended January 31, 2022 we generated cash flows from financing activities of $19,184.

*<u>Plan of Operation and Funding</u>*

We expect that working capital requirements will continue to be funded through a combination of our existing funds and further issuances of securities. Our working capital requirements are expected to increase in line with the growth of our business.

Existing working capital, further advances and debt instruments, and anticipated cash flow are expected to be adequate to fund our operations over the next three months. We have no lines of credit or other bank financing arrangements. Generally, we have financed operations to date through the proceeds of the private placement of equity and debt instruments. In connection with our business plan, management anticipates additional increases in operating expenses and capital expenditures relating to: (i) acquisition of inventory; (ii) developmental expenses associated with a start-up business; and (iii) marketing expenses. We intend to finance these expenses with further issuances of securities, and debt issuances. Thereafter, we expect we will need to raise additional capital and generate revenues to meet long-term operating requirements. Additional issuances of equity or convertible debt securities will result in dilution to our current shareholders. Further, such securities might have rights, preferences or privileges senior to our common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, we may not be able to take advantage of prospective new business endeavors or opportunities, which could significantly and materially restrict our business operations. We will have to raise additional funds in the next twelve months in order to sustain and expand our operations. We currently do not have a specific plan of how we will obtain such funding; however, we anticipate that additional funding will be in the form of equity financing from the sale of our common stock. We have and will continue to seek to obtain short-term loans from our directors, although no future arrangement for additional loans has been made. We do not have any agreements with our directors concerning these loans. We do not have any arrangements in place for any future equity financing.

*<u>Off-Balance Sheet Arrangements</u>*

As of the date of this Quarterly Report, we do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

*<u>Going Concern</u>*

The financial statements have been prepared "assuming that we will continue as a going concern," which contemplates that we will realize our assets and satisfy our liabilities and commitments in the ordinary course of business.

*<u>ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</u>*

No report required.

*<u>ITEM 4. CONTROLS AND PROCEDURES</u>*

Our management is responsible for establishing and maintaining a system of disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) that is designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer's management, including its principal executive officer or officers and principal financial officer or officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

An evaluation was conducted under the supervision and with the participation of our management of the effectiveness of the design and operation of our disclosure controls and procedures as of January 31, 2023. Based on that evaluation, our management concluded that our disclosure controls and procedures were not effective as of such date to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms. Such officer also confirmed that there was no change in our internal control over financial reporting during the nine-month period ended January 31, 2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

**PART II. OTHER INFORMATION**

*<u>ITEM 1. LEGAL PROCEEDINGS</u>*

Management is not aware of any legal proceedings contemplated by any governmental authority or any other party involving us or our properties. As of the date of this Quarterly Report, no director, officer or affiliate is (i) a party adverse to us in any legal proceeding, or (ii) has an adverse interest to us in any legal proceedings. Management is not aware of any other legal proceedings pending or that have been threatened against us or our properties.

*<u>ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</u>*

No report required.

*<u>ITEM 3. DEFAULTS UPON SENIOR SECURITIES</u>*

No report required.

*<u>ITEM 4. MINE SAFETY DISCLOSURES</u>*

Not applicable.

*<u>ITEM 5. OTHER INFORMATION</u>*

No report required.

*<u>ITEM 6. EXHIBITS</u>*

The following exhibits are included as part of this report by reference:

---

| | |
|:---|:---|
| 31.1 | [Certification of Chief Executive Officer and Chief Financial Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a).](orion_ex3101.htm) |
| 32.1 | [Certification pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002.](orion_ex3201.htm) |
| 101.INS | Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document) |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in Ashdod Kalonite 9-57 Israel 7724233.

---

| | |
|:---|:---|
|  | **ORION BLISS CORP.** |
| March 13, 2023 | By: /s/ Alexandra Solomovskaya |
|  | President, Treasurer and Secretary |
|  | (Principal Executive, Financial and Accounting Officer) |

---

In accordance with the requirements of the Securities Act of 1933, this registration statement was signed by the following persons in the capacities and on the dates stated.

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| /s/ *Alexandra Solomovskaya* |  |  |
| Alexandra Solomovskaya | President, Treasurer, Secretary and Director<br> (Principal Executive, Financial and Accounting Officer) | March 13, 2023 |

---

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION PURSUANT TO<br> 18 U.S.C. ss 1350, AS ADOPTED PURSUANT TO<br> SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002** 

I, Alexandra Solomovskaya, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Orion Bliss Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a- 15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| Date: March 13, 2023 |
| */s/ Alexandra Solomovskaya* |
| Alexandra Solomovskaya |
| President, Treasurer, Secretary and Director |
| (Principal Executive, Financial and Accounting Officer) |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION PURSUANT TO<br> 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO<br> SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002** 

I, Alexandra Solomovskaya, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Quarterly Report on Form 10-Q of Orion Bliss Corp. for the period ended January 31,
 2023 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
 and

(2) the information contained in the Report fairly presents, in all material respects, the financial
 condition and results of operations of Orion Bliss Corp.

Dated: March 13, 2023

---

| |
|:---|
| */s/ Alexandra Solomovskaya* |
| Alexandra Solomovskaya |
| President, Treasurer, Secretary and Director |
| (Principal Executive, Financial and Accounting Officer) |

---